Feature Channels: Regenerative Medicine

Filters close
Released: 29-Nov-2022 12:25 PM EST
Primeras investigaciones sobre una solución acelular para la incontinencia urinaria por esfuerzo
Mayo Clinic

La regeneración del músculo esquelético y los síntomas de la incontinencia urinaria por esfuerzo en una investigación preclínica indican una mejora tras el uso de una sustancia acelular descubierta en Mayo Clinic. Los equipos del Dr. en Ciencias Atta Behfar y del Dr. Emanuel Trabuco encabezaron esta investigación en una colaboración entre los Departamentos de Medicina Cardiovascular y de Obstetricia y Ginecología de Mayo Clinic. El artículo se ha publicado en NPJ Regenerative Medicine.

Released: 29-Nov-2022 12:20 PM EST
压力性尿失禁无细胞解决方案的早期研究
Mayo Clinic

临床前研究中的再生骨骼肌和压力性尿失禁的症状表明,在使用妙佑医疗国际(Mayo Clinic) 发现的无细胞物质后,症状有所改善。Atta Behfar医学博士/博士和Emanuel Trabuco医学博士的团队在妙佑医疗国际心血管医学部和妇产科之间开展合作,领导了这项研究。这篇论文发表在NPJ Regenerative Medicine上。

Released: 29-Nov-2022 12:20 PM EST
Pesquisa inicial em uma solução livre de células para incontinência urinária por esforço
Mayo Clinic

Músculo esquelético regenerado e sintomas de incontinência urinária por esforço em pesquisa pré-clínica sugerem melhora após o uso de uma substância livre de células descoberta na Mayo Clinic. As esquipes do Dr. Atta Behfar, Ph.D. e do Dr. Emanuel Trabuco lideram a pesquisa em uma colaboração entre os Departamentos de Medicina Cardiovascular e de Obstetrícia e Ginecologia da Mayo Clinic. O artigo foi publicado na revista NPJ Regenerative Medicine.

Newswise: Yu Xin (Will) Wang joins Sanford Burnham Prebys to advance regenerative medicine
28-Nov-2022 12:00 PM EST
Yu Xin (Will) Wang joins Sanford Burnham Prebys to advance regenerative medicine
Sanford Burnham Prebys

Molecular biologist Yu Xin (Will) Wang, Ph.D., has joined Sanford Burnham Prebys as an assistant professor in the Development, Aging, and Regeneration Program to uncover the ways muscle, nerve and immune cells work together to overcome disease.

Released: 16-Nov-2022 12:20 PM EST
Ancient disease has potential to regenerate livers, study finds
University of Edinburgh

Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ.

Released: 16-Nov-2022 10:50 AM EST
ReMDO collaborates with SAS in New RegeneratOR Testbed with Advanced Smart Manufacturing Capabilities
Wake Forest Institute for Regenerative Medicine

The Regenerative Medicine Development Organization (ReMDO) and analytics leader SAS are collaborating on the ReMDO RegeneratOR Test Bed, a novel regenerative medicine endeavor in North Carolina.

   
Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Newswise: Silicon nanochip could treat traumatic muscle loss
Released: 9-Nov-2022 11:05 AM EST
Silicon nanochip could treat traumatic muscle loss
Indiana University

Technology that can change skin tissue into blood vessels and nerve cells also shows promise as a treatment for traumatic muscle loss.

Newswise: Cedars-Sinai Awarded $8 Million to Launch New Stem Cell Clinic
Released: 28-Oct-2022 7:20 PM EDT
Cedars-Sinai Awarded $8 Million to Launch New Stem Cell Clinic
Cedars-Sinai

Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medicine, foster greater collaboration with eight similar clinics across the state and help educate the public about stem cell and related therapies.

Released: 24-Oct-2022 5:15 PM EDT
The New York Stem Cell Foundation Names Dr. Derrick Rossi as Interim CEO
New York Stem Cell Foundation (NYSCF)

The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO of NYSCF.

Newswise: Researchers find that different stem cells are responsible for the repair of different kinds of bone injuries
19-Oct-2022 5:05 PM EDT
Researchers find that different stem cells are responsible for the repair of different kinds of bone injuries
UT Southwestern Medical Center

The discovery that different bone-forming stem cells are responsible for different aspects of bone maintenance and repair will allow us to focus future bone regeneration efforts

   
Newswise: New Master’s Degree Prepares Future Regenmed Scientists, Business Leaders
Released: 11-Oct-2022 10:05 AM EDT
New Master’s Degree Prepares Future Regenmed Scientists, Business Leaders
Wake Forest Institute for Regenerative Medicine

A new master’s degree program to prepare next and future generations of STEM professionals and business leaders for the regenerative medicine field has been established at the Wake Forest University School of Medicine in collaboration with regenerative medicine experts at the Wake Forest Institute for Regenerative Medicine (WFIRM).

Newswise: Scientists Discover Protein Partners that Could Heal Heart Muscle
Released: 6-Oct-2022 4:40 PM EDT
Scientists Discover Protein Partners that Could Heal Heart Muscle
University of North Carolina School of Medicine

Scientists at the UNC School of Medicine have made a significant advance in the promising field of cellular reprogramming and organ regeneration, and the discovery could play a major role in future medicines to heal damaged hearts.

Released: 28-Sep-2022 4:10 PM EDT
Single cell research spotlights the role of DNA methylation on cell fate decisions
Babraham Institute

Research from the Reik lab at the Babraham Institute has advanced our understanding of the role of DNA methylation during the earlier stages of development.

Released: 26-Sep-2022 11:00 AM EDT
A impressão 3D como uma nova opção para regeneração de laringe após câncer ou lesão traumática
Mayo Clinic

A Mayo Clinic está usando a impressão 3D como uma nova opção para cura de laringe após câncer ou lesão traumática. O Dr. David Lott, M.D., otorrinolaringologista e cirurgião de cabeça e pescoço da Mayo Clinic, é um especialista que pode falar sobre o procedimento pioneiro que usa engenharia de tecidos e bioimplantes 3D para regeneração de laringe, também conhecida como caixa de voz.

Released: 26-Sep-2022 10:50 AM EDT
تنبيه الخبراء: خيارات لتجديد الحنجرة
Mayo Clinic

فينيكس ، أريزونا — تستخدم Mayo Clinic الطباعة ثلاثية الأبعاد كخيار جديد وعنق Mayo لعلاج الحنجرة بعد السرطان أو الصدمة. ديفيد لوت ، دكتوراه في الطب ، اختصاصي طب الأنف والأذن والحنجرة وجراح رئيس كلينك ، هو خبير يمكنه التحدث عن إجراء رائد يستخدم زراعة حيوية ثلاثية الأبعاد وهندسة الأنسجة لتجديد الحنجرة ، والمعروف أكثر باسم صندوق الصوت.

Released: 26-Sep-2022 10:45 AM EDT
专家提醒:喉部再生方案
Mayo Clinic

妙佑医疗国际(Mayo Clinic)正在使用3D打印这种新方案来治疗癌症或创伤性损伤后的喉部。David Lott医学博士是妙佑医疗国际的耳鼻喉科医生和头颈外科医生。在这篇文章中,他将作为技术专家介绍一项可利用3D生物移植物和组织工程来实现喉部(通常称为喉头)再生的开创性手术。Lott博士还是妙佑医疗国际亚利桑那州院区再生医学中心的副主任。

Newswise: NUS scientists develop novel technique to grow meat in the lab using magnetic field
Released: 26-Sep-2022 12:05 AM EDT
NUS scientists develop novel technique to grow meat in the lab using magnetic field
National University of Singapore (NUS)

A team of scientists from the National University of Singapore has devised a novel technique of using magnetic pulses to grow cultured meat. When animal cells are exposed to a pulsed magnetic field, they release growth-inducing molecules to help them proliferate, without the need for animal serum. This approach is slaughter-free, greener, cleaner, safer and cheaper.

Released: 22-Sep-2022 10:00 AM EDT
Advertencia del experto: Opciones para la regeneración de la laringe 
Mayo Clinic

Mayo Clinic usa impresiones tridimensionales como una nueva opción para restablecer la laringe después del cáncer o de un traumatismo. El Dr. David Lott, otorrinolaringólogo y cirujano de cabeza y cuello en Mayo Clinic, es un experto que puede hablar acerca de un procedimiento pionero que usa implantes biológicos trimensionales e ingeniería de tejidos para regenerar la laringe.

Released: 13-Sep-2022 10:20 AM EDT
Phase II Clinical Trial Suggests Treatment Pre-Surgery Safe and Effective Option for Localized Non-Small Cell Lung Cancer
Ohio State University Wexner Medical Center

New study data shows that the immuno-oncology drug, atezolizumab is a safe and effective treatment for stage IB-IIIB non-small cell lung cancer patients prior to lung cancer surgery, according to a new study led by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute as part of the national Lung Cancer Mutation Consortium 3 study. Researchers found that the survival of patients in this new study was far better – about 80% at three years post treatment and approximately twice as good as that which would be expected with surgery and chemotherapy alone. Study investigators also report data showing that the presence of high numbers of natural killer (NK) cells – a type of immune cell found in the blood before treatment – were associated with poor immunotherapy treatment effectiveness in this study. Patients with high levels of these cells might benefit from the addition of NK-specific therapy.

Newswise: MIMEDX Joins the RegenMed Hub
Released: 12-Sep-2022 9:45 AM EDT
MIMEDX Joins the RegenMed Hub
Wake Forest Institute for Regenerative Medicine

MIMEDX is the latest addition to the RegeneratOR Innovation Accelerator, located in the Regenerative Medicine Hub (RegenMed Hub), a rapidly growing regenerative medicine ecosystem based in the Innovation Quarter of Winston-Salem.

Released: 8-Sep-2022 11:10 AM EDT
How can you explain the pain? Get the latest research on pain management in the Pain channel
Newswise

The latest research and expert commentary on pain management.

Released: 7-Sep-2022 5:05 PM EDT
جسر تجديدي إلى عملية الزراعة لأبٍ شاب
Mayo Clinic

مايو كلينك رائدة في تحسين الإجراءات التجديدية التي تشكل جسرًا إلى عملية الزراعة. حيث توفر هذه الإجراءات خيارات جديدة لتقوية الصحة وإعادة بنائها بينما ينتظر المرضى هبة الحياة.

Released: 22-Aug-2022 3:45 PM EDT
Find expert commentary on the monkeypox outbreak here
Newswise

The latest research and expert commentary on the monkeypox outbreak.

Released: 3-Aug-2022 11:05 AM EDT
UF Center for Regenerative Medicine recruiting for trial on potential therapy for autoimmune disorders
University of Florida

The Phase I clinical trial will test umbilical cord-derived stem cells to treat two rare autoimmune conditions.

Released: 2-Aug-2022 2:35 PM EDT
Newts Unleashed: Limb Muscle Regeneration Needs Metamorphosis and Body Growth
University of Tsukuba

Unknown to passersby, a modest little creature with amazing abilities lives and breeds in the forests and paddy fields of Japan. Now, researchers from Japan have discovered how these amphibians' superpowers are unleashed.

Released: 2-Aug-2022 1:05 PM EDT
Expert Alert: Options for laryngeal regeneration
Mayo Clinic

Mayo Clinic is using 3D printing as a new option to heal the larynx after cancer or traumatic injury.

Released: 1-Aug-2022 9:00 AM EDT
RTT Medical Joins RegenMed Hub Innovation Accelerator
Wake Forest Institute for Regenerative Medicine

RTT Medical is the newest tenant of the Innovation Accelerator, a support ecosystem created by the RegenMed Development Organization (ReMDO) to help companies with new or emerging regenerative medicine technologies speed up the translation of products to patients.

Released: 29-Jul-2022 2:05 PM EDT
Don't give up the fight. Read the latest news about drug and antibiotic resistance
Newswise

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

Released: 25-Jul-2022 5:40 PM EDT
تأكيد من طبيب أخصائي: العلاج الإشعاعي بحزم البروتونات لسرطان العظام يحافظ على الأنسجة المحيطة
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا: يعد تموز/يوليو هو شهر التوعية بالساركوما وللفت الانتباه لمجموعة من السرطانات التي تبدأ في العظام أو الأنسجة الرخوة في الجسم. هناك أكثر من 70 نوعاً من الساركوما، منها سرطان العظام. وتشمل طرق علاج سرطان العظام الجراحة والعلاج الكيميائي والعلاج الإشعاعي والعلاج الإشعاعي بحزم البروتونات الذي يستهدف الخلايا السرطانية.

Released: 25-Jul-2022 2:00 PM EDT
Advertencia Del Experto: Terapia Con Haz De Protones Para CáNcer De Hueso Salva Al Tejido Circundante
Mayo Clinic

Julio es el mes para concienciar sobre el sarcoma y llamar la atención sobre aquel grupo de cánceres que empiezan en los huesos o en los tejidos blandos del cuerpo. Hay más de 70 tipos de sarcoma, entre ellos, el cáncer de hueso.

Released: 25-Jul-2022 2:00 PM EDT
Alerta Do Especialista: Terapia Por Feixe De PróTons Para CâNcer óSseo Poupa Tecido Circundante
Mayo Clinic

Julho é o Mês da Conscientização do Sarcoma, chamando a atenção para um grupo de cânceres que começa nos ossos ou nos tecidos moles do corpo. Existem mais de 70 tipos de sarcoma, incluindo o câncer ósseo.

Released: 25-Jul-2022 12:25 PM EDT
DNA Recombinations Are Widespread in Human Genomes and Are Implicated in Both Development and Disease
RIKEN

Scientists from the RIKEN Center for Integrative Medical Sciences in Japan in collaboration with other researchers from around the world have discovered that recombinations of specific genomic sequences that are repeated millions of times in the genome of each of our cells are pervasively found in both normal and in disease states. Identifying the mechanisms that lead to this myriad of recombinations involving DNA sequences that were once considered as “junk”, may be crucial to understanding how our cells develop and what can make them unhealthy.

Released: 22-Jul-2022 9:40 AM EDT
Bioautomation - Combining Drug Discovery and 3D-Printing
2022 AACC Annual Scientific Meeting Press Program

A loaboratory robot with full 3D-capabilities and proven Nanolitre pipetting enables new applications for life sciences

Released: 19-Jul-2022 6:05 PM EDT
Eliksa Therapeutics launched with University of Utah’s commercial and clinical-stage regenerative medicine technology
University of Utah

Eliksa Therapeutics, a regenerative medicine company developing novel therapeutics for a range of debilitating diseases, announced today it has launched with investments from the University of Utah (U) and Militia Hill Ventures (MHV) to develop and commercialize multiple clinical programs using the regenerative medicine technology developed at the U.

   
Newswise: Scientists Develop Blueprint for Turning Stem Cells Into Sensory Interneurons
Released: 19-Jul-2022 1:05 PM EDT
Scientists Develop Blueprint for Turning Stem Cells Into Sensory Interneurons
University of California, Los Angeles (UCLA), Health Sciences

Key takeaways: • Just like the real thing. The stem cell–derived interneurons, which play a role in sensations like touch and pain, are indistinguishable from their real-life counterparts in the body. • Tomorrow’s therapies. In addition to potential treatments for injury-related sensation loss, the discovery could lead to new methods for screening drugs for chronic pain. • Moving forward. While stem cells from mice were used in the research, scientists are now working to replicate the findings with human cells.

Newswise: Study Suggests That C. Difficile Drives Some Colorectal Cancers
Released: 14-Jul-2022 10:00 AM EDT
Study Suggests That C. Difficile Drives Some Colorectal Cancers
Johns Hopkins Medicine

Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.

Released: 13-Jul-2022 9:55 AM EDT
استبيان مايو كلينك يبحث في سبب طلب المرضى علاجات الخلايا الجذعية
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا— في إحدى الدراسات الأولى من نوعها، حللت مايو كلينك مجموعة كبيرة من المرضى لفهم دوافعهم للبحث عن علاجات بالخلايا الجذعية وما إذا كانت التوقعات مبنية على العلم. ويمكن أن تساعد هذه النتائج خبراء الرعاية الصحية على التعامل مع الادعاءات المضللة وتقديم المشورة للمرضى بشكل أفضل.

Newswise: Research Shows Investigational Drug Fosters Nerve Repair After Injury
Released: 12-Jul-2022 1:30 PM EDT
Research Shows Investigational Drug Fosters Nerve Repair After Injury
University of Birmingham

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma.

Newswise: Scientists Find Trigger That Sets Off Metastasis in Pancreatic Cancer
Released: 29-Jun-2022 11:35 AM EDT
Scientists Find Trigger That Sets Off Metastasis in Pancreatic Cancer
University of California, Berkeley

Suppressing enzyme that removes oxygen from methionine sparks metastatic spread of cancer.

Released: 27-Jun-2022 4:25 PM EDT
Tissue Model Reveals Key Players in Liver Regeneration
Massachusetts Institute of Technology (MIT)

The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.

Newswise: Karallief Announces Granted Patent for Easy Climb Fast Acting Formula Clinically Shown to Improve Joint Comfort
Released: 27-Jun-2022 9:00 AM EDT
Karallief Announces Granted Patent for Easy Climb Fast Acting Formula Clinically Shown to Improve Joint Comfort
Karallief

Karallief® Inc., a leading nutraceutical ingredient company that researches, develops, and distributes clinically studied herbal extract ingredient formulas, announced today that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 11,364,255 for Karallief® Easy Climb®.

   
Newswise: Wistar Scientists Identify Novel Therapeutic Approach to Re-Activate Immune Response Against Tumors
Released: 21-Jun-2022 10:00 AM EDT
Wistar Scientists Identify Novel Therapeutic Approach to Re-Activate Immune Response Against Tumors
Wistar Institute

Wistar scientists identified that inhibiting therapeutic target KDM5A boosts a person’s immune response to tumors.

   
Released: 17-Jun-2022 3:05 PM EDT
Tenascin Proteins Inhibit Regeneration of Cell Envelope
Ruhr-Universität Bochum

Researchers at Ruhr-Universität Bochum have been studying the role of the two proteins tenascin C and tenascin R in multiple sclerosis. In this disease, cells of the immune system destroy the myelin sheaths, i.e. the sheaths of the nerve cells.

Newswise: New Solution for Stem Cell Manufacturing
Released: 16-Jun-2022 1:30 PM EDT
New Solution for Stem Cell Manufacturing
University of Technology, Sydney

Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost.



close
1.06721